Dermatology. Women and Children s Services

Similar documents
Atopic Eczema with detail on how to apply wet wraps

LRI Children s Hospital

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57

Steroid use in managing your child s Atopic Eczema

Childhood Eczema Flowchart

Recommended management of eczema in older patients

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57

Children s Hospital Of Wisconsin

ATOPIC ECZEMA. What are the aims of this leaflet?

The management of chronic urticaria in primary care for adults and children

Things that go bump: Wart & Molluscum

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:

Clinico Pathological Test SCPA605-Essential Pathology

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level

TCIs are only available on prescription and are usually started by a dermatology specialist.

ACNE. What are the aims of this leaflet?

Paediatric Eczema. Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

DOES URTICARIA RULE YOUR LIFE?

Teledermatology Paediatric eczema. Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital

Dermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated)

What are the symptoms of a vulval skin condition?

Dermatology GP Referral Guidelines

Rashes Not To Be Missed In Children

15 minute eczema consultation

Common Dermatological Conditions in Adults in Ghana. Margaret Lartey FWACP

Molluscum Contagiosum in Adults & Kids

Dermatology Round Up

Anogenital Warts. Questions & Answers

Learning Circle: Jan 26, 2011 Childhood Eczema

Dr David Orchard MBBS FACD

An Everyday Guide to Eczema

Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age

X-Plain Acne Reference Summary

ACNE. Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service

RELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN

Patch testing. Dermatology Department Patient Information Leaflet

The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis

Case Studies From econsults Lessons Learned

Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital

FACTSHEET ADULT SEBORRHOEIC DERMATITIS. What is seborrhoeic dermatitis? Who gets and why? What does it look like?

Summer health survival guide.

Pediatric Dermatology. Wingfield Rehmus, MD MPH BC Children s Hospital

MALE GENITAL (PENIS) LICHEN SCLEROSUS

Urticaria. Appearance. Epidemiology [1] Aetiology [2]

Warts. Dr. Ghassan Salah

Diphencyprone (DCP) treatment

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

ACNE VULGARIS: DIAGNOSIS AND TREATMENT

Skin Problems. Issues for a Child. Skin Problems. Paediatric Palliative Care For Home Based Carers. Common in children with HIV

Integumentary System

OSPAP Programme Skin Disorders

Oral problems. Mouth Ulcer and Cold sore. Lec-2

Primary Care Guidelines for the Management of Atopic Eczema 10/07100

Acne vulgaris is a disease of the pilosebaceous unit (i.e., the sebaceous glands and adjacent hair follicle).

EXTERNAL ANOGENITAL WARTS

PHARMACY PRACTICE I PHCY280 (2 CREDITS); PHCY280L (1CREDIT) SUMMER Christy Mary Sam

F r e q u e n t l y A s k e d Q u e s t i o n s

1. Wounds may be left exposed with some ointment applied to the stitch line:

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs

Eczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse.

Eczema management: how to control the itch

A Resource Kit for Career Counsellors

What s causing this rash?

FACTSHEET CICLOSPORIN. Introduction. How does ciclosporin work? When is ciclosporin used?

The Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah

CANDIDIASIS (WOMEN) Single Episode. Clinical Features. Diagnosis. Management

0BCore Safety Profile. Pharmaceutical form(s)/strength: Cream 1% DK/H/PSUR/0009/005 Date of FAR:

Education. Acne (acne vulgaris) is a. Putting out the spot fires. ClinicalReview AUTHOR. Learning objectives

Healthy Skin and Skin Infections. Prepared by the Midland Region Child Health Action Group Skin Subgroup

1. Wounds may be left exposed with some ointment applied to the stitch line:

Cutaneous reactions to targeted therapies. Stavonnie Patterson, MD, FAAD Northwestern University Feinberg School of Medicine March 6, 2017

PHOTOTHERAPY. With narrowband UVB, the light tubes produce a narrow part of the UVB spectrum. Two wavelengths

PRIMARY CARE MANAGEMENT OF CHILDHOOD ATOPIC ECZEMA

PAEDIATRIC ACUTE CARE GUIDELINE. Impetigo. This document should be read in conjunction with this DISCLAIMER

Drug Allergy A Guide to Diagnosis and Management

Title Management of Impetigo Protocol in MIUs and WICs. Author s job title Professional Lead, Minor Injuries Unit Directorate

Treatments used Topical including cleansers and moisturizer Oral medications:

TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

A Child with Eczema: A Parent s Guide

THE PLASTIC SURGERY CLINIC

ECZEMA. Introduction. Differential diagnoses. Starship Children s Health Clinical Guideline

Speaker and paid consultant for Galderma, Novartis and Jansen. No other potential conflicts to disclose. Review of Relevant Physiology

Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland

Eczema & Dermatitis Clinical features: Histopathological features: Classification:

Cetuximab in Combination with Irinotecan based Chemotherapy for the 1 st, 2 nd and 3 rd treatment Metastatic of Colorectal Cancer

Cholestatic jaundice Chronic kidney disease Iron deficiency +/-anaemia. Hepatoma Diabetes Leukaemia

PRE-CARE & POST CARE FOR ALL TREATMENTS

IMMUNODEFICIENCIES PRIMARY ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES

What you need to know about ECZEMA

What you need to know about ECZEMA

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27

REFERRAL GUIDELINES - SUMMARY

Periocular skin cancer

Identifying and managing dermatologic toxicities associated with EGFR-inhibitor therapy. An educational resource for healthcare professionals

Burns and Scalds. Treatment and Management. Accident and Emergency Department. Royal Surrey County Hospital. Patient information leaflet

Emergency Dermatology. Emergency Dermatology

Transcription:

Women and Children s Services Dermatology Disclaimer: The recommendations contained in this guideline do not indicate an exclusive course of action, or serve as a standard of medical care. Variations, taking individual circumstances into account, may be appropriate. The authors of these guidelines have made considerable efforts to ensure the information on which they are based is accurate and up to date. The authors accept no responsibility for any inaccuracies, information perceived as misleading, or the success of any treatment regimen detailed in the guidelines.

Women and Children s Services Atopic Dermatitis Atopic dermatitis affects 20% of children and in the majority resolves with age. It is genetically determined but many environmental factors, such as drying of the skin by detergents and sweating, play a key role in disease exacerbation. Diagnostic Criteria The child must have an itchy skin rash plus 3 or more of the following: 1. A history of generally dry skin 2. Personal or family history of asthma or hay fever 3. History of involvement of skin creases 4. Visible flexural eczema (or cheeks or extensor limbs if under 4 years) 5. Onset under the age of 2 years (only used if over 4 years old) Treatment 1. Avoid aggravating factors e.g. irritants (soap and shampoo), heat, woollen/nylon clothing and animal hair 2. Moisturisation Daily bath with bath oil and/or a soap substitute helps to prevent infection and improve hydration of the skin by trapping moisture in the skin once emollient has been applied Moisturise 3 times daily with as greasy a moisturiser as tolerated by the patient e.g. liquid paraffin 50% in white soft paraffin 3. Topical Corticosteroids Applied twice daily to all active areas until redness and itching have cleared (usually 3 days) Scaling and hyperpigmentation take longer to clear but do not require active treatment. Treatment needs to be repeated for relapses which may be weekly. 1% hydrocortisone ointment should be used on the face Eumovate strength steroid ointment to the trunk and limbs Disclaimer: The recommendations contained in this guideline do not indicate an exclusive course of action, or serve as a standard of medical care. Variations, taking individual circumstances into account, may be appropriate. The authors of these guidelines have made considerable efforts to ensure the information on which they are based is accurate and up to date. The authors accept no responsibility for any inaccuracies, information perceived as misleading, or the success of any treatment regimen detailed in the guidelines.

Women and Children s Services Common Complications 1. Impetiginisation Recognised by weeping or crusting of the skin Treat with topical crystacide or a steroid and antimicrobial/antibiotic combination Treat with an oral antibiotic after swabbing if generalized NB Continuous use of Topical fucidic acid may give rise to resistant Staph. Aureus 2. Herpetic superinfection Recognised by widespread monomorphic round vesicles or erosions Treat with oral aciclovir if mild Refer urgently if severe or send to A&E out of hours Indications for Referral 1. Failure of eczema to respond to the above approach, in particular to the regular use of a greasy moisturiser and a eumovate strength steroid 2. Suspected herpetic superinfection Disclaimer: The recommendations contained in this guideline do not indicate an exclusive course of action, or serve as a standard of medical care. Variations, taking individual circumstances into account, may be appropriate. The authors of these guidelines have made considerable efforts to ensure the information on which they are based is accurate and up to date. The authors accept no responsibility for any inaccuracies, information perceived as misleading, or the success of any treatment regimen detailed in the guidelines.

Dermatology - Atopic Eczema Patient Pathway April 2005 Patient Presentation Atopic eczema is a common relapsing and remitting skin disease that often improves with advancing age. However regular treatment is often required over a prolonged period. Acute infected eczema Chronic lichenified flexural ezcema Acute erythrodermic eczema Treatment of mild disease: Bath emollients + additional antiseptic Soap substitutes and emollients used regularly Mild to moderate potency topical steroid to affected areas on trunk and limbs Mild topical steroid for facial eczema Sedating antihistamine orally if sleep disturbed. Treatment of moderate disease: Bath emollients and soap substitutes as above Moderate potency topical steroid to trunk and limbs consider short course of potent topical steroid for flares Mild topical steroid for facial eczema consider topical tacrolimus or pimecrolimus if poor response to topical steroid 1% Ichthammol in zinc ointment / paste bandages for flexures Sedative antihistamines at night e.g. chlorpheniramine or hydroxyzine When bacterial infection suspected, use topical antibiotic if localised, oral flucloxacillin or erythromycin if widespread. Treatment of severe disease: As above but refer to Dermatologist for: inpatient treatment or out-patient dressings consideration of systemic therapy. Dermatology Consultant Criteria for referral to Dermatology Consultant: Failure to respond to continuing use of moderately potent steroids Sleep problems and psychosocial upset Recurrent secondary infection Growth retardation for paediatric assessment Clinical history of relevant food allergies for investigation and dietary advice only if appropriate. Eczema herpeticum: arrange emergency referral by phone Dermatology Nurse Specialist Criteria for referral to Dermatology Nurse Specialist: Diagnosis established previously in Secondary Care Relapse of the disease which failed to respond to topical therapy in Primary Care Request for further counselling and/or education including demonstration of topical treatment including wet wraps. Follow up in Patient Secondary Care Page 1 of 2

Dermatology - Atopic Eczema Patient Pathway April 2005 Therapeutic tips: Advise patient to continue normal diet unless clear history of reacting to specific foods. Prescribe adequate quantities of emollients, soap substitutes (+/- antiseptics) and bath additives. Reassure patient that weak or moderate topical corticosteroids are safe and effective when applied to active areas of eczema only Give advice on lifestyle factors (avoid biological washing powders and fabric conditioners, cigarette smoke or hairy pets). Advise patient to use cotton clothing. In adults and adolescents give advice on suitable career options. History of adverse reaction to topical treatment may be an indication for patch testing. Consider secondary bacterial infection if eczema weeping or crusted. Useful Information for Patients www.skincarecampaign.org www.eczema.org www.bad.org.uk Information about the development and future updating of these Patient Pathways is available on the CCI website: www.cci.scot.nhs.uk Photographs have been kindly provided by clinicians on the group. Page 2 of 2

Women and Children s Services Protocol for the Treatment of Warts Many warts resolve spontaneously and therefore a policy of wait & see is reasonable Facial warts Wart paints cannot be used on the face If the child wants active treatment then cryotherapy with liquid nitrogen is the only real option Hand and plantar warts None - wait for natural resolution Topical treatment As a first option children should have a three month trial of wart paint applied nightly after filing Covering with an adhesive plaster may improve efficacy If this fails consider cryotherapy Cryotherapy with liquid nitrogen Freeze wart until an ice ball covers the whole wart and there is a collarette for 10 seconds Allow to thaw Repeat freeze for at further 10 seconds Repeat freezing every three weeks for 6-10 cycles Disclaimer: The recommendations contained in this guideline do not indicate an exclusive course of action, or serve as a standard of medical care. Variations, taking individual circumstances into account, may be appropriate. The authors of these guidelines have made considerable efforts to ensure the information on which they are based is accurate and up to date. The authors accept no responsibility for any inaccuracies, information perceived as misleading, or the success of any treatment regimen detailed in the guidelines.

Women and Children s Services Referrals to secondary care RHSC Yorkhill has implemented the patient pathways developed by the centre for change and Innovation for NHS Scotland. These can be found at http:/www.pathways.scot.nhs.uk/index.htm. The majority of warts require no treatment. For this reason, we can only accept referrals for facial and genital warts, and painful warts which have been present for more than 2 years. Please note: Cryotherapy is painful and is rarely tolerated by children < 7 years or for multiple warts. Disclaimer: The recommendations contained in this guideline do not indicate an exclusive course of action, or serve as a standard of medical care. Variations, taking individual circumstances into account, may be appropriate. The authors of these guidelines have made considerable efforts to ensure the information on which they are based is accurate and up to date. The authors accept no responsibility for any inaccuracies, information perceived as misleading, or the success of any treatment regimen detailed in the guidelines.

Dermatology - Viral Warts Patient Pathway April 2005 Warts are caused by a common viral infection, the human papillomavirus (HPV). Most resolve spontaneously within a year or two. They may vary in appearance depending Common hand warts on the type of HPV, the anatomical site involved and the host immune response. Deep plantar wart (verruca) Can be tender on pressure Patient Presentation Mosaic plantar warts Slow to resolve compared with other types of wart Most patients with viral warts can be managed in primary care. Management Consider no treatment as warts usually resolve spontaneously Self treatment daily with salicylic or glutaraldehyde paints or gels after paring the warts Continue treatment for at least Consider 3 weekly cryotherapy but use in combination with topical three months by practice nurse therapy. in non-responders Self treatment with daily salicylic paint or formaldehyde gel Paring of plantar warts with disposable file enhances treatment response Referral to practice nurse for consideration of cryotherapy three weekly for up to 10 treatments: single or double freeze thaw cycle Patients with painful plantar warts can be treated with corn plasters Consider referral to podiatrist? Refer Secondary Care Criteria for referral Dermatologist to Symptomatic warts persistent for at least two years and unresponsive to topical agents and cryotherapy Diagnostic uncertainty especially in the elderly Multiple recalcitrant warts in the immunosuppressed Plane warts Flat topped pink or pale brown Often on face or other sun exposed sites Plane warts often resolve spontaneously Avoid cryotherapy Apply topical retinoic acid if persistent Filiform facial warts Do not apply wart paints Treat filiform facial warts with careful seconds to the wart but avoid surrounding skin Repeat every 2 or 3 weeks. Patient cryotherapy Secondary Care for 5-10 Page 1 of 2 Useful Information for Patients www.patient.co.uk www.bad.org.uk

Dermatology - Viral Warts Patient Pathway April 2005 Therapeutic tips: Do not use salicylic acid on the face. Cryotherapy should be administered by appropriately trained staff to minimise the risk of excessive tissue damage. Cryotherapy may cause hyper- or hypopigmentation Diagnostic doubt over solitary wart: remove by curettage for histopathology. Children with verrucae should not be barred from swimming but can wear verruca socks. Anogenital warts: refer patients to genito-urinary medicine for infection screening and cervical cytology Information about the development and future updating of these Patient Pathways is available on the CCI website: www.cci.scot.nhs.uk Photographs have been kindly provided by clinicians on the group. Page 2 of 2

Dermatology - Molluscum Contagiosum Patient Pathway draft updated Dec 2007 Patient Presentation Molluscum Contagiosum is a common pox virus infection of the skin. Most infections resolve spontaneously within a few months. Clinical appearance Flesh coloured or pink papules with umbilicated centre. Eczema around molluscum contagiosum MANAGEMENT In the majority of the cases no treatment is required as spontaneous resolution occurs. Squeeze lesions with tweezers after bathing then apply antiseptic cream. Topical antiseptic may minimise secondary infection Consider topical salicylic acid gel or topical imiquimod Cryotherapy by practice nurse (avoid in young children). Curettage with use of topical anaesthetic cream: send specimen for histopathology if there is diagnostic doubt.? Refer Secondary Care Criteria for referral to Dermatologist Diagnostic uncertainty Extensive, painful, inflamed lesions Immunosuppressed patients Resolving molluscum contagiosum Therapeutic tips: Avoid sharing towels and sponges. Eczema around molluscum: treat with emollients, 1% ichthammol paste or mild topical steroid. Ano-genital molluscum contagiosum: treat with podophyllotoxin paint once weekly - adults: consider referral of patient to genitourinary medicine for infection screen - children: infection commonly acquired from swimming pools. Picture shows extensive molluscum in immunosuppressed patient If associated conjunctivitis is present: refer to Ophthalmologist Useful Information for Patients Patient Secondary Care www.cci.scot.nhs.uk www.bad.org.uk www.patient.co.uk www.doctoronline.nhs.uk www.nhs.uk

Dermatology - Acne Patient Pathway April 2005 Non inflamed comedones Patient Presentation More extensive inflamed lesions on face and trunk Deep inflamed cysts and scarring Useful Information for Patients www.stopspots.org www.m2w3.com/acne www.bad.org.uk Inflamed papules and pustules Mild to moderate acne Patients with mild to moderate acne can usually be managed in. Prolonged treatment may be required with regular review to encourage patient compliance. Topical treatment: Keratolytics Benzoyl peroxide } Advice from pharmacist on over the counter preparations Retinoids: Adapalene Isotretinoin Tretinoin Topical clindamycin, erythromycin or tetracycline alone or combined with benzoyl peroxide, retinoids or zinc. Systemic therapy Oral antibiotics for at least 6 months. Under 12 years old: Erythromycin 500mg bd 12 years and over: Oxytetracycline 500mg bd Doxycycline 100mg od Lymecycline 425mg od Minocycline 100mg od Erythromycin 500mg bd In women consider additional anti-androgen treatment e.g. cyproterone and ethinyloestradiol combination Treatment failures: referral for consideration of oral isotretinoin therapy, but advise patients about potential side effects including teratogenicity in women. Severe cystic acne with scarring Commence systemic antibiotic therapy and refer immediately for consideration of systemic isotretinoin, indicating the reasons justifying an urgent referral. Patient Secondary Care www.cci.scot.nhs.uk Therapeutic tips: Benzoyl peroxide starting at 2.5% increasing to 5% or 10% may help reduce irritant effects. Topical retinoids can cause irritation therefore build up frequency and duration of application over 2-3 weeks. Assess response to oral antibiotics at 2 to 3 months. If poor response, change to alternative oral antibiotic but continue for 6 months minimum. Minocycline may have additional side effects therefore preferred as second line. Regular follow up in to encourage patient compliance and to ensure that response to treatment is satisfactory. Patients referred to Dermatology should continue prescribed treatment until seen in the out-patient clinic. Dermatology Consultant Criteria for referral Primarily for consideration of oral isotretinoin in patients with: Poor response to at least six months of one or two different oral antibiotics plus topical therapy Severe Acne (extensive disease or nodules or scars) Severe psychological upset.

Dermatology - Urticaria Patient Pathway updated December 07 Patient Presentation Acute urticaria Patients present with sudden onset of very itchy, transient wheals which resolve within hours. May be accompanied by angioedema. Chronic urticaria: Regular episodes persisting for more than 3 months, fluctuating in intensity. Associated dermographism. Spontaneous resolution is the usual outcome. Dermographism induced by application of firm pressure to skin Angio-oedema of airways without urticaria Most patients with urticaria can be managed in. Causes of acute urticaria: detailed history may identify possible triggers e.g. medication. Laboratory tests (RAST or CAP) are rarely necessary and only to confirm suspected specific triggers. SKIN PATCH TESTING IS INAPPROPR IATE Treatment of acute urticaria: Non sedating antihistamines: fexofenadine, loratidine, mizolastine, cetirizine. Sedative antihistamines: use in addition at night if sleep is disrupted e.g. chlorpheniramine, hydroxyzine. Continue regular treatment until symptoms subside. Oral corticosteroids: Short course only for severe acute urticaria. Causes of chronic urticaria: Physical e.g. cold, pressure, dermographism Auto-immune aetiology. Treatment of chronic urticaria: Non-sedating antihistamines: fexofenadine, loratidine, desloratidine, mizolastine, cetirizine, levocetirizine. Sedating antihistamines: additionally at night if sleep disturbed. Topical antipruritic: 1% menthol in aqueous cream. Causes: Idiopathic angioedema C1 esterase inhibitor deficiency is rare and specific treatment is required. GP Investigation of angioedema without urticaria: Check complement and C1 esterase inhibitor levels Treatment: non sedating antihistamines as above Patient Self administration of adrenaline by Epi-pen injector Patient must understand the indications for and how to self-administer. Two devices must be carried Patient must seek urgent medical advice immediately after use of the Epi-pen. Patient Secondary Care Dermatology Consultant Criteria for referral Persistent urticaria unresponsive to 3 different anti-antihistamines each for 4-6 weeks Urticarial vasculitis with associated joint pains, persistent wheals and bruising Immunologist Consider referral to an immunologist for patients with angioedema of unknown aetiology. Useful Information for Patients www.patient.co.uk www.bad.org.uk NHS24: 08454 24 24 24

Dermatology - Urticaria Patient Pathway April 05 Diagnostic tips Itchy red wheals occurring or recurring in crops Transient nature usually resolving in hours No residual scarring or bruising Elicitation of dermographism Possible coexistence of angioedema Therapeutic tips Advise patient to avoid suspected triggers: stress, heat, tight clothing, alcohol, caffeine. Stop any histamine releasing drugs eg: aspirin, codeine, ACE inhibitors, penicillin, non-steroidal anti-inflammatory drugs Change to alternative anti-histamine after 4-6 weeks if one agent has not helped. Consider combination of two drugs. Antihistamine administration should be related to the time pattern of symptoms. Avoid long term oral steroids in chronic urticaria. Information about the development and future updating of these Patient Pathways is available on the CCI website: www.cci.scot.nhs.uk Photographs have been kindly provided by clinicians on the group. Page 2 of 2